ALDH1A3 and cancer: Complementing the extensive transcriptomics previously completed on ALDH1A3-expressing cancer cells (Coyle et al., 2017; Marcato et al., 2015) with metabolomics is a potential strategy to identify pro-metastatic pathways that are not obvious by gene expression data alone.